Founded in Paris in 1920, Gide is a leading international law firm with 12 offices spread throughout the world.
Gide is physically present in six regions of the world, with 11 offices, enabling it to act on cases globally.
3 December 2015
Deals | France | M&A / Corporate
Gide advises Guerbet, a pioneer in the field of contrast agents for medical imaging, on the completion of the acquisition of US leading specialty biopharmaceutical company Mallinckrodt’s Contrast Media and Delivery Systems business (CMDS).
Guerbet completed the definitive acquisition of Mallinckrodt’s CMDS activity, present in nearly 50 countries, on 27 November. In the terms of the agreement signed on 27 July 2015, the transaction is valued at USD 270 million, and is fully paid in cash and debt financed. The operation results in the creation of a new unit numbering some 2,500 employees for a turnover of approximately EUR 800 million, making Guerbet one of the world leaders in contrast products and imaging and services solutions.
The acquisition, which was closed on 27 November 2015 simultaneously in over 28 countries, was subject to approval by the competent regulatory authorities.
The Gide team advising Guerbet comprises partner Pierre-Antoine Dubecq, Matthias Grolier, Aménis Bererhi and Rachel Phillips on M&A aspects; Jean-Hyacinthe de Mitry, Adelaide de Laguiche on intellectual property aspects; partner Eric Cartier-Millon, counsel Thomas Binet and Anne Moriceau on financing aspects; partner Dimitri Dimitrov, Charles Terdjman and Gabriel Curnier on antitrust aspects; with the assistance of Gide’s Hong Kong, Istanbul, London, Warsaw and Shanghai offices. Goodwin Procter (USA), Blakes (Canada) and William Fry (Ireland) also provided legal counsel to Guerbet.
